At a Glance
- Tasks: Lead Phase 3 trials and post-approval studies in rare diseases from start to finish.
- Company: Cycle Pharmaceuticals, a leader in rare disease research.
- Benefits: Hybrid work model, competitive salary, and opportunities for professional growth.
- Other info: Collaborative environment with a focus on innovation and quality.
- Why this job: Make a real difference in patients' lives by managing impactful clinical studies.
- Qualifications: Experience in clinical study management and strong organisational skills.
The predicted salary is between 50715 - 61985 $ per year.
Cycle Pharmaceuticals is seeking a Senior Clinical Study Manager to lead the operational delivery of Phase 3 trials and Phase 4 post-approval studies across rare diseases from feasibility to final report.
The role reports to the Associate Director of Clinical Operations and requires oversight of timelines, budgets, quality and regulatory compliance.
You will own studies, coordinate site selection, supply planning, and DMC activities while collaborating with cross-functional teams.
Senior Clinical Study Manager – Rare Disease, Phase 3 (Hybrid) in Cambridge employer: Cycle Pharmaceuticals
Cycle Pharmaceuticals is dedicated to making a meaningful impact in the field of rare diseases, with a strong focus on oncology, hematology, neurology, and rare metabolic conditions. The company fosters a collaborative work environment that emphasizes professional growth and the importance of every patient. Employees benefit from hybrid working arrangements and the opportunity to contribute to innovative pharmaceutical development.
